CL2017002709A1 - Compuestos de pirazolo - y triazolo - pirimidina antivirales contra vsr - Google Patents
Compuestos de pirazolo - y triazolo - pirimidina antivirales contra vsrInfo
- Publication number
- CL2017002709A1 CL2017002709A1 CL2017002709A CL2017002709A CL2017002709A1 CL 2017002709 A1 CL2017002709 A1 CL 2017002709A1 CL 2017002709 A CL2017002709 A CL 2017002709A CL 2017002709 A CL2017002709 A CL 2017002709A CL 2017002709 A1 CL2017002709 A1 CL 2017002709A1
- Authority
- CL
- Chile
- Prior art keywords
- compounds
- triazolo
- pyrazolo
- vsr
- pyrimidine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- 241000725643 Respiratory syncytial virus Species 0.000 abstract 2
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 abstract 1
- OGEBRHQLRGFBNV-RZDIXWSQSA-N chembl2036808 Chemical class C12=NC(NCCCC)=NC=C2C(C=2C=CC(F)=CC=2)=NN1C[C@H]1CC[C@H](N)CC1 OGEBRHQLRGFBNV-RZDIXWSQSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 208000030925 respiratory syncytial virus infectious disease Diseases 0.000 abstract 1
- YWBFPKPWMSWWEA-UHFFFAOYSA-O triazolopyrimidine Chemical class BrC1=CC=CC(C=2N=C3N=CN[N+]3=C(NCC=3C=CN=CC=3)C=2)=C1 YWBFPKPWMSWWEA-UHFFFAOYSA-O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
<p>La invención se refiere a compuestos de pirazolo- y triazolo-pirimidina sustituidos novedosos de fórmula (I) que tienen actividad antiviral, en particular, que tienen una actividad inhibidora sobre la replicación del virus sincitial respiratorio (VSR). La invención se refiere además a composiciones farmacéuticas que comprenden estos compuestos y a los compuestos para su uso en el tratamiento de la infección por el virus sincitial respiratorio.</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562153753P | 2015-04-28 | 2015-04-28 | |
| US201562204390P | 2015-08-12 | 2015-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2017002709A1 true CL2017002709A1 (es) | 2018-04-20 |
Family
ID=55860847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2017002709A CL2017002709A1 (es) | 2015-04-28 | 2017-10-25 | Compuestos de pirazolo - y triazolo - pirimidina antivirales contra vsr |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US10208048B2 (es) |
| EP (1) | EP3288942B1 (es) |
| JP (1) | JP6698693B2 (es) |
| KR (1) | KR102538565B1 (es) |
| CN (1) | CN107531715B (es) |
| AU (1) | AU2016254700B2 (es) |
| BR (1) | BR112017023263B1 (es) |
| CA (1) | CA2981404C (es) |
| CL (1) | CL2017002709A1 (es) |
| CY (1) | CY1125329T1 (es) |
| DK (1) | DK3288942T3 (es) |
| EA (1) | EA035689B1 (es) |
| ES (1) | ES2905550T3 (es) |
| HR (1) | HRP20211728T1 (es) |
| HU (1) | HUE057626T2 (es) |
| IL (1) | IL254750B (es) |
| JO (1) | JO3637B1 (es) |
| LT (1) | LT3288942T (es) |
| MA (1) | MA41974A (es) |
| MX (1) | MX369040B (es) |
| PH (1) | PH12017501958B1 (es) |
| PL (1) | PL3288942T3 (es) |
| PT (1) | PT3288942T (es) |
| SG (1) | SG11201708786SA (es) |
| SI (1) | SI3288942T1 (es) |
| TW (1) | TWI703146B (es) |
| UA (1) | UA120448C2 (es) |
| WO (1) | WO2016174079A1 (es) |
| ZA (1) | ZA201707320B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO3637B1 (ar) | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
| TW201932470A (zh) | 2017-11-29 | 2019-08-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 具有抗ｒｓｖ活性之吡唑并嘧啶 |
| TW201936193A (zh) * | 2017-12-05 | 2019-09-16 | 愛爾蘭商健生科學愛爾蘭無限公司 | 使用組合產品治療ｒｓｖ |
| AU2019216260B2 (en) * | 2018-01-31 | 2023-03-02 | Janssen Sciences Ireland Unlimited Company | Cycloalkyl substituted pyrazolopyrimidines having activity against RSV |
| KR20210005569A (ko) * | 2018-04-23 | 2021-01-14 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | Rsv에 대한 활성을 갖는 헤테로방향족 화합물 |
| EP3787617A4 (en) * | 2018-05-03 | 2021-09-08 | Georgia State University Research Foundation Inc. | RESPIRATORY SYNCYTIAL VIRUS (RSV) REPLICATION INHIBITORS AND THEIR USES |
| AU2019389616A1 (en) * | 2018-11-26 | 2021-04-29 | Janssen Sciences Ireland Unlimited Company | Further heteroaromatic compounds having activity against RSV |
| CA3124783A1 (en) | 2018-12-27 | 2020-07-02 | Taisho Pharmaceutical Co., Ltd. | Pyrazolo[1,5-a]pyrimidine macrocyclic compound |
| CA3136287A1 (en) | 2019-05-23 | 2020-11-26 | Guillaume Jean Maurice Mercey | Other heteroaromatic compounds having activity against rsv |
| CN111440173B (zh) * | 2020-03-27 | 2021-05-14 | 山东大学 | 一种pi3k抑制剂的制备方法 |
| WO2022020891A1 (en) * | 2020-07-27 | 2022-02-03 | Esfam Biotech Pty Ltd | Methods of prophylaxis and treatment of corona virus |
| WO2022020889A1 (en) * | 2020-07-27 | 2022-02-03 | Esfam Biotech Pty Ltd | Method of treatment of cytomegalovirus |
| CN116425754A (zh) * | 2021-12-30 | 2023-07-14 | 苏州爱科百发生物医药技术有限公司 | 芳杂双环化合物及其抗病毒用途 |
| WO2023245166A2 (en) * | 2022-06-17 | 2023-12-21 | Trawsfynydd Therapeutics, Inc. | Compounds for treatment of a coronavirus infection |
| WO2024121262A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
| WO2024121263A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
| WO2024121264A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
| WO2024121261A1 (en) | 2022-12-09 | 2024-06-13 | Syngenta Crop Protection Ag | Insecticidal compound based on pyrazole derivatives |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996019483A1 (en) | 1994-12-22 | 1996-06-27 | Biochem Pharma Inc. | Low molecular weight bicyclic thrombin inhibitors |
| AU714072B2 (en) | 1995-06-29 | 1999-12-16 | Banyu Pharmaceutical Co., Ltd. | Combinations of inhibitors of farnesyl-protein transferase |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| US5972966A (en) | 1996-12-05 | 1999-10-26 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5977134A (en) | 1996-12-05 | 1999-11-02 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US6177443B1 (en) | 1997-03-07 | 2001-01-23 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use |
| KR20020063837A (ko) | 1999-07-19 | 2002-08-05 | 시오노기세이야쿠가부시키가이샤 | 아실옥시메톡시카르보닐 측쇄를 갖는 삼환 화합물 |
| EP1113007A1 (en) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| AU2002332659A1 (en) | 2001-08-21 | 2003-03-03 | Sepracor, Inc. | 2-substituted piperidines that are ligands for monoamine receptors and transporters |
| MXPA04010441A (es) | 2002-04-23 | 2005-02-14 | Shionogi & Co | Derivado de pirazolo[1,5-a]pirimidina e inhibidor de nad(p)h oxidasa que contiene el mismo. |
| ATE415961T1 (de) | 2002-09-20 | 2008-12-15 | Medisyn Technologies Inc | Therapeutische verwendung von mitgliedern der n,n-dicylcohexyl-2-hydroxy-7,7- dimethylbicycloä2.2.1ühept-1- ylmethanesulphonamide-familie |
| WO2004029042A1 (en) | 2002-09-26 | 2004-04-08 | Pfizer Limited | Pyrazole derivatives as reverse transcriptase inhibitors |
| AU2003275632A1 (en) | 2002-10-25 | 2004-05-13 | Mitsubishi Pharma Corporation | N-oxide compounds |
| AR043633A1 (es) | 2003-03-20 | 2005-08-03 | Schering Corp | Ligandos de receptores de canabinoides |
| WO2004087153A2 (en) | 2003-03-28 | 2004-10-14 | Chiron Corporation | Use of organic compounds for immunopotentiation |
| FR2856596B1 (fr) | 2003-06-27 | 2007-04-27 | Bioprojet Soc Civ | Nouvelle association medicamenteuse psychiatrique et utilisation d'une antagoniste ou agoniste inverse du recepteur h3 de l'histamine pour preparer un medicament prevenant des effets indesirables de psychotropes. |
| JPWO2005035516A1 (ja) | 2003-10-10 | 2006-12-21 | 小野薬品工業株式会社 | 新規縮合複素環化合物およびその用途 |
| US7323567B2 (en) | 2003-10-30 | 2008-01-29 | Boehringer Ingelheim (Canada) Ltd. | RSV polymerase inhibitors |
| AR046959A1 (es) * | 2003-12-18 | 2006-01-04 | Tibotec Pharm Ltd | Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio |
| US8598193B2 (en) | 2003-12-24 | 2013-12-03 | Biota Scientific Management Pty Ltd. | Polycyclic agents for the treatment of respiratory syncytial virus infections |
| JP4894518B2 (ja) | 2004-09-13 | 2012-03-14 | 小野薬品工業株式会社 | 含窒素複素環誘導体およびそれらを有効成分とする薬剤 |
| TW200626155A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| WO2007044085A2 (en) | 2005-05-19 | 2007-04-19 | Xenon Pharmaceuticals Inc. | Heteroaryl compounds and their uses as therapeutic agents |
| ATE529424T1 (de) * | 2005-06-20 | 2011-11-15 | Tibotec Pharm Ltd | 1-ää2-amino-3-(substituiertes alkyl)-3h- benzimidazolylümethylü-3-substituierte-1,3- dihydrobenzimidazol-2-one als replikationshemmer des respiratorischen syncytialvirus |
| US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
| CN101360736A (zh) | 2005-11-23 | 2009-02-04 | 阿斯利康(瑞典)有限公司 | L-丙氨酸衍生物 |
| US20080021026A1 (en) * | 2006-07-20 | 2008-01-24 | Mehmet Kahraman | Benzothiophene inhibitors of rho kinase |
| US20080176870A1 (en) | 2006-11-20 | 2008-07-24 | Bert Nolte | Heterobicyclic metalloprotease inhibitors |
| MX2010001650A (es) | 2007-08-10 | 2010-08-02 | Glaxosmithkline Llc | Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales. |
| JP2011506335A (ja) | 2007-12-06 | 2011-03-03 | シェーリング コーポレイション | γ−セクレターゼ調節剤 |
| TW201024307A (en) | 2008-09-10 | 2010-07-01 | Kalypsys Inc | Aminopyrimidine inhibitors of histamine receptors for the treatment of disease |
| US8829027B2 (en) | 2008-10-23 | 2014-09-09 | Boehringer Ingelheim International Gmbh | Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use |
| US20100204265A1 (en) | 2009-02-09 | 2010-08-12 | Genelabs Technologies, Inc. | Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections |
| KR20100101054A (ko) | 2009-03-07 | 2010-09-16 | 주식회사 메디젠텍 | 세포핵에서 세포질로의 ｇｓｋ３의 이동을 억제하는 화합물을 함유하는 세포핵에서 세포질로의 ｇｓｋ３ 이동에 의해 발생되는 질환의 치료 또는 예방용 약학적 조성물 |
| JP2012521428A (ja) | 2009-03-23 | 2012-09-13 | メルク・シャープ・エンド・ドーム・コーポレイション | 疼痛治療用のｐ２ｘ３受容体アンタゴニスト |
| US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
| PE20110679A1 (es) | 2009-06-11 | 2011-10-20 | Abbvie Bahamas Ltd | Derivados de (4-tert-butilfenil)pirrolidin-2,5-difenil como inhibidores del hcv |
| US8486938B2 (en) * | 2010-06-24 | 2013-07-16 | Gilead Sciences, Inc. | Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
| CA2825098C (en) * | 2011-01-27 | 2020-03-10 | Universite De Montreal | Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators |
| EA027855B1 (ru) * | 2012-04-17 | 2017-09-29 | Гайлид Сайэнсиз, Инк. | Соединения и способы для противовирусной терапии |
| TWI652014B (zh) * | 2013-09-13 | 2019-03-01 | 美商艾佛艾姆希公司 | 雜環取代之雙環唑殺蟲劑 |
| CA2924527C (en) | 2013-09-20 | 2022-07-12 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compounds for treating prostate cancer |
| WO2015106025A1 (en) | 2014-01-09 | 2015-07-16 | The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone | Substituted benzoxazine and related compounds |
| KR101551313B1 (ko) | 2014-07-28 | 2015-09-09 | 충남대학교산학협력단 | 신규한 인덴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 망막 질환의 예방 또는 치료용 약학적 조성물 |
| CA2965741C (en) | 2014-11-03 | 2022-05-17 | Iomet Pharma Ltd | Pharmaceutical compound |
| EA032081B1 (ru) | 2014-12-08 | 2019-04-30 | Янссен Сайенсиз Айрлэнд Юси | ЗАМЕЩЕННЫЕ ПИПЕРИДИНОМ ПРОИЗВОДНЫЕ ПИРАЗОЛО[1,5-a]ПИРИМИДИНА С ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ РЕПЛИКАЦИИ РЕСПИРАТОРНО-СИНЦИТИАЛЬНОГО ВИРУСА (RSV) |
| CN105777632A (zh) | 2015-01-09 | 2016-07-20 | 成都贝斯凯瑞生物科技有限公司 | 芳环并氮杂环衍生物及其应用 |
| JO3637B1 (ar) * | 2015-04-28 | 2020-08-27 | Janssen Sciences Ireland Uc | مركبات بيرازولو- وترايازولو- بيريميدين مضادة للفيروسات rsv |
-
2016
- 2016-04-25 JO JOP/2016/0080A patent/JO3637B1/ar active
- 2016-04-26 TW TW105112899A patent/TWI703146B/zh not_active IP Right Cessation
- 2016-04-27 PT PT167193879T patent/PT3288942T/pt unknown
- 2016-04-27 EP EP16719387.9A patent/EP3288942B1/en active Active
- 2016-04-27 US US15/570,054 patent/US10208048B2/en active Active
- 2016-04-27 SG SG11201708786SA patent/SG11201708786SA/en unknown
- 2016-04-27 AU AU2016254700A patent/AU2016254700B2/en not_active Ceased
- 2016-04-27 MA MA041974A patent/MA41974A/fr unknown
- 2016-04-27 EA EA201792370A patent/EA035689B1/ru unknown
- 2016-04-27 HR HRP20211728TT patent/HRP20211728T1/hr unknown
- 2016-04-27 CN CN201680024585.8A patent/CN107531715B/zh not_active Expired - Fee Related
- 2016-04-27 BR BR112017023263-4A patent/BR112017023263B1/pt not_active IP Right Cessation
- 2016-04-27 DK DK16719387.9T patent/DK3288942T3/da active
- 2016-04-27 ES ES16719387T patent/ES2905550T3/es active Active
- 2016-04-27 HU HUE16719387A patent/HUE057626T2/hu unknown
- 2016-04-27 WO PCT/EP2016/059392 patent/WO2016174079A1/en not_active Ceased
- 2016-04-27 PL PL16719387T patent/PL3288942T3/pl unknown
- 2016-04-27 MX MX2017013884A patent/MX369040B/es active IP Right Grant
- 2016-04-27 KR KR1020177033587A patent/KR102538565B1/ko active Active
- 2016-04-27 UA UAA201711550A patent/UA120448C2/uk unknown
- 2016-04-27 JP JP2017556537A patent/JP6698693B2/ja not_active Expired - Fee Related
- 2016-04-27 LT LTEPPCT/EP2016/059392T patent/LT3288942T/lt unknown
- 2016-04-27 SI SI201631398T patent/SI3288942T1/sl unknown
- 2016-04-27 CA CA2981404A patent/CA2981404C/en active Active
-
2017
- 2017-09-27 IL IL254750A patent/IL254750B/en active IP Right Grant
- 2017-10-25 CL CL2017002709A patent/CL2017002709A1/es unknown
- 2017-10-26 PH PH12017501958A patent/PH12017501958B1/en unknown
- 2017-10-27 ZA ZA2017/07320A patent/ZA201707320B/en unknown
-
2019
- 2019-02-11 US US16/272,934 patent/US10611769B2/en active Active
-
2020
- 2020-03-30 US US16/835,073 patent/US11084826B2/en not_active Expired - Fee Related
-
2022
- 2022-01-25 CY CY20221100055T patent/CY1125329T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2017002709A1 (es) | Compuestos de pirazolo - y triazolo - pirimidina antivirales contra vsr | |
| BR112017013491A2 (pt) | compostos de pirimidina fundida para o tratamento de hiv | |
| CL2017000379A1 (es) | Compuestos de pirrolopirimidina usados como agonistas del receptor de tipo toll. 7 (tlr7) | |
| MX389349B (es) | Derivados de ácido borónico y usos terapéuticos de los mismos. | |
| BR112017013440A2 (pt) | compostos de isoquinolina para o tratamento de hiv | |
| MX382671B (es) | Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington | |
| ECSP11011310A (es) | Análogos carba - nucleósido para tratamiento antiviral | |
| NZ733174A (en) | Quinazoline derivatives used to treat hiv | |
| SV2018005750A (es) | Derivados de compuestos de indol sustituidos como inhibidores de la replicacion virica del dengue | |
| UY37645A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| PE20151867A1 (es) | Polipeptidos f de prefusion del virus sincicial respiratorio (rsv )solubles y estabilizados | |
| CL2016001973A1 (es) | Derivados de nucleosido sustituidos con 4' -difluorometilo como inhibidores de la replicación de arn de la influenza. | |
| MX381488B (es) | Indoles para su uso en la infección por el virus de la gripe. | |
| EA201690687A1 (ru) | Ингибиторы репликации вируса иммунодефицита | |
| UY37646A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| MX2018011785A (es) | Derivados de indolina sustituidos como inhibidores de la replicacion viral del dengue. | |
| CO2018008421A2 (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
| ECSP18061667A (es) | Pirimidinas sustituidas con arilo para su uso en la infección por virus influenza | |
| CU20170109A7 (es) | Derivado de quinoleina para tratar y prevenir infecciones virales | |
| BR112017003242A2 (pt) | composto, métodos para tratar infecção por vírus e para fabricação de um medicamento, composição farmacêutica, e, uso de um composto. | |
| CU24519B1 (es) | Derivados de aminotiazol útiles como agentes antivíricos | |
| PE20150167A1 (es) | (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel | |
| EA201790495A1 (ru) | Фармацевтические композиции длительного действия | |
| CR20160529A (es) | Composiciones farmacéuticas para tratar enfermedades infecciosas | |
| EA201692063A1 (ru) | Спиросоединения мочевины в качестве противовирусных соединений против rsv |